Present and Future Treatment of Myasthenia Gravis
- 19 March 1987
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 316 (12) , 743-745
- https://doi.org/10.1056/nejm198703193161209
Abstract
Editorial from The New England Journal of Medicine — Present and Future Treatment of Myasthenia GravisKeywords
This publication has 8 references indexed in Scilit:
- Preliminary Results of a Double-Blind, Randomized, Placebo-Controlled Trial of Cyclosporine in Myasthenia GravisNew England Journal of Medicine, 1987
- The Effects of Cyclosporin A on the Immune SystemAnnual Review of Immunology, 1985
- Treatment of experimental myasthenia gravis with cyclosporin AClinical Immunology and Immunopathology, 1985
- Cloning and sequence analysis of calf cDNA and human genomic DNA encoding α-subunit precursor of muscle acetylcholine receptorNature, 1983
- KINETICS OF UNRESPONSIVENESS INDUCED BY A SHORT COURSE OF CYCLOSPORIN ATransplantation, 1982
- THE NATURAL COURSE OF MYASTHENIA GRAVIS AND EFFECT OF THERAPEUTIC MEASURESAnnals of the New York Academy of Sciences, 1981
- Mechanisms of acetylcholine receptor loss in myasthenia gravis.Journal of Neurology, Neurosurgery & Psychiatry, 1980
- MYASTHENIA GRAVIS, CORTICOSTEROIDS, ANTICHOLINESTERASESAnnals of the New York Academy of Sciences, 1976